Effects of Esmolol Infusion on Hemodynamic Responses to Isometric Handgrip
Status:
Withdrawn
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
This study will test the hypothesis that Esmolol hydrochloride, a beta-1 selective blocker,
improves myocardial oxygen (O2) supply-demand balance at rest and during isometric (handgrip)
stress in adults with peripheral artery disease (PAD) and healthy controls.